SCHEMBL13097642

SCHEMBL13097642

CCOC(=O)[C@H](CC)NC(=O)CC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.58
KMT2A Q03164 2/20 0.50
POLB P06746 1/20 0.50
CAD P27708 1/20 0.44
CYP2C9 P11712 2/20 0.42
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
ALDH1A1 P00352 3/20 0.37
NOD1 Q9Y239 3/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14047527 0.85 CYP2C9 (0.43) L3MBTL1KMT2APOLBCYP2C9
SCHEMBL27733059 0.84 L3MBTL1 (0.50) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL5020127 0.84 L3MBTL1 (0.50) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL5020136 0.82 L3MBTL1 (0.49) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL29108810 0.82 CYP2C9 (0.41) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL3898983 0.81 L3MBTL1 (0.50) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL11435235 0.81 L3MBTL1 (0.50) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL4189292 0.80 L3MBTL1 (0.84) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL4189297 0.80 L3MBTL1 (0.84) L3MBTL1KMT2APOLBCADCYP2C9
SCHEMBL30124016 0.79 L3MBTL1 (0.49) L3MBTL1KMT2APOLBCADCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653238-B2 Compositions and methods for transport of molecules with enhanced release properties across biological barriers THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2014-02-18 US disclosed
US-20100255499-A1 COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100255499-A1 COMPOSITIONS AND METHODS FOR TRANSPORT OF MOLECULES WITH ENHANCED RELEASE PROPERTIES ACROSS BIOLOGICAL BARRIERS SLC2A9, SLC43A1, SLC2A8 L3MBTL1 2873/4885KMT2A 4253/4885POLB 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.